Suppr超能文献

Mig-6基因敲除诱导血管平滑肌细胞内膜增生。

Mig-6 gene knockout induces neointimal hyperplasia in the vascular smooth muscle cell.

作者信息

Lee Ju Hee, Choung Sorim, Kim Ji Min, Lee Jung Uee, Kim Koon Soon, Kim Hyun Jin, Jeong Jae-Wook, Ku Bon Jeong

机构信息

Department of Internal Medicine, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 301-721, Republic of Korea.

Department of Pathology, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Republic of Korea.

出版信息

Dis Markers. 2014;2014:549054. doi: 10.1155/2014/549054. Epub 2014 Dec 10.

Abstract

Although advances in vascular interventions can reduce the mortality associated with cardiovascular disease, neointimal hyperplasia remains a clinically significant obstacle limiting the success of current interventions. Identification of signaling pathways involved in migration and proliferation of vascular smooth muscle cells (SMCs) is an important approach for the development of modalities to combat this disease. Herein we investigate the role of an immediate early response gene, mitogen-inducible gene-6 (Mig-6), in the development of neointimal hyperplasia using vascular smooth muscle specific Mig-6 knockout mice. We induced endoluminal injury to one side of femoral artery by balloon dilatation in both Mig-6 knockout and control mice. Four weeks following injury, the artery of Mig-6 knockout mice demonstrated a 5.3-fold increase in the neointima/media ratio compared with control mice (P = 0.04). In addition, Mig-6 knockout vascular SMCs displayed an increase in both cell migration and proliferation compared with wild-type SMCs. Taken together, our data suggest that Mig-6 plays a critical role in the development of atherosclerosis. This finding provides new insight into the development of more effective ways to treat and prevent neointimal hyperplasia, particularly in-stent restenosis after percutaneous vascular intervention.

摘要

尽管血管介入技术的进步可以降低心血管疾病相关的死亡率,但新生内膜增生仍然是限制当前介入治疗成功的一个具有临床意义的障碍。识别参与血管平滑肌细胞(SMC)迁移和增殖的信号通路是开发对抗这种疾病方法的重要途径。在此,我们使用血管平滑肌特异性Mig-6基因敲除小鼠,研究即刻早期反应基因丝裂原诱导基因-6(Mig-6)在新生内膜增生发展中的作用。我们通过球囊扩张对Mig-6基因敲除小鼠和对照小鼠的一侧股动脉造成腔内损伤。损伤后四周,与对照小鼠相比,Mig-6基因敲除小鼠的动脉新生内膜/中膜比值增加了5.3倍(P = 0.04)。此外,与野生型SMC相比,Mig-6基因敲除的血管SMC在细胞迁移和增殖方面均有所增加。综上所述,我们的数据表明Mig-6在动脉粥样硬化的发展中起关键作用。这一发现为开发更有效的治疗和预防新生内膜增生的方法提供了新的见解,特别是经皮血管介入术后的支架内再狭窄。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa6/4276689/8f341219276b/DM2014-549054.001.jpg

相似文献

1
Mig-6 gene knockout induces neointimal hyperplasia in the vascular smooth muscle cell.
Dis Markers. 2014;2014:549054. doi: 10.1155/2014/549054. Epub 2014 Dec 10.
5
The Actin-Binding Protein Drebrin Inhibits Neointimal Hyperplasia.
Arterioscler Thromb Vasc Biol. 2016 May;36(5):984-93. doi: 10.1161/ATVBAHA.115.306140. Epub 2016 Mar 24.
6
Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):760-8. doi: 10.1161/ATVBAHA.112.300614. Epub 2013 Feb 14.
7
MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):122-33. doi: 10.1161/ATVBAHA.115.306672. Epub 2015 Nov 12.
8
Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia.
Int J Biol Sci. 2022 Aug 8;18(13):5154-5167. doi: 10.7150/ijbs.75577. eCollection 2022.
9
Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):317-27. doi: 10.1161/ATVBAHA.115.305974. Epub 2015 Dec 10.
10
Targeted disruption of the prostaglandin E2 E-prostanoid 2 receptor exacerbates vascular neointimal formation in mice.
Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1739-47. doi: 10.1161/ATVBAHA.111.226142. Epub 2011 Jun 2.

引用本文的文献

1
Role of Mig-6 in adipose tissue: Implications for glucose metabolism and insulin resistance.
PLoS One. 2025 Feb 12;20(2):e0314289. doi: 10.1371/journal.pone.0314289. eCollection 2025.
5
Mitogen-Inducible Gene 6 Inhibits Angiogenesis by Binding to SHC1 and Suppressing Its Phosphorylation.
Front Cell Dev Biol. 2021 Feb 22;9:634242. doi: 10.3389/fcell.2021.634242. eCollection 2021.
6
The Role of ERRFI1+808T/G Polymorphism in Diabetic Nephropathy.
Int J Mol Cell Med. 2019 Winter;8(Suppl1):49-55. doi: 10.22088/IJMCM.BUMS.8.2.49. Epub 2019 Jun 15.

本文引用的文献

1
The epidermal growth factor receptor and its ligands in cardiovascular disease.
Int J Mol Sci. 2013 Oct 15;14(10):20597-613. doi: 10.3390/ijms141020597.
2
Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.
Cancer Res. 2013 Aug 15;73(16):5090-9. doi: 10.1158/0008-5472.CAN-13-0241. Epub 2013 Jun 27.
4
Mig-6 plays a critical role in the regulation of cholesterol homeostasis and bile acid synthesis.
PLoS One. 2012;7(8):e42915. doi: 10.1371/journal.pone.0042915. Epub 2012 Aug 17.
5
Progress and challenges in translating the biology of atherosclerosis.
Nature. 2011 May 19;473(7347):317-25. doi: 10.1038/nature10146.
6
Consequences of epidermal growth factor receptor (ErbB1) loss for vascular smooth muscle cells from mice with targeted deletion of ErbB1.
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1643-52. doi: 10.1161/ATVBAHA.111.223537. Epub 2011 Apr 21.
7
Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.
J Clin Endocrinol Metab. 2011 Mar;96(3):E554-65. doi: 10.1210/jc.2010-1800. Epub 2010 Dec 29.
8
In-stent restenosis in the drug-eluting stent era.
J Am Coll Cardiol. 2010 Nov 30;56(23):1897-907. doi: 10.1016/j.jacc.2010.07.028.
9
The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression.
Oncogene. 2010 Jul 1;29(26):3770-80. doi: 10.1038/onc.2010.126. Epub 2010 Apr 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验